Paragon Care Limited (ASX: PGC) - Share Price
- Current share price for PGC : $0.145
Paragon Care Limited (PGC), an ASX-listed company, is a provider durable medical equipment, medical devices, consumable medical products, and maintenance of technical medical equipment to the health, aged care and veterinary markets throughout Australia, New Zealand and Asia, as well as the distribution of pharmaceuticals, medical consumables, and complementary medicines to the Australian healthcare market.
PGC General Information +
| ASX Code | PGC |
| Website | N/A |
| Industry/Sector | Health Care Distributors |
| Market Cap ($M) | 240 |
| PGC Share Price | $0.145 |
| Day High | $0.150 |
| Day Low | $0.140 |
| Last Close | $0.145 |
| PGC Share Price Movement | - ( No change ) |
Prices as at 13:50, 9 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Paragon Care Limited (PGC) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 0.6¢ | 100% | 18 Sep 2023 | 6 Oct 2023 | - | - | - |
| Result | 0.6¢ | 100% | 14 Mar 2023 | 5 Apr 2023 | - | - | - |
| HFResult | 0.6¢ | 100% | 12 Sep 2022 | 4 Oct 2022 | - | - | - |
See all dividends from Paragon Care Limited (PGC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Paragon Care Limited (PGC) price-sensitive announcements
PGC - Infinity Group Recovery and Earnings Update
Paragon Care Limited has provided an update on its financial exposure to the Infinity Reta
Paragon Care Limited (PGC)
1 Jun 2026 | 8:29 AM
1 Jun 2026 | 8:29 AM
PGC - 1H26 Investor Presentation
Paragon Care Limited reported its FY26 half-year financial results, revealing a 2.9% incre
Paragon Care Limited (PGC)
25 Feb 2026 | 9:02 AM
25 Feb 2026 | 9:02 AM
PGC - 1H26 Results Release
Paragon Care Limited, a leading healthcare provider in the Asia Pacific region, announced
Paragon Care Limited (PGC)
25 Feb 2026 | 9:01 AM
25 Feb 2026 | 9:01 AM
PGC - 1H26 Appendix 4D and Half Year Report
Paragon Care Limited's Half Year Report for the period ending 31 December 2025 reveals a c
Paragon Care Limited (PGC)
25 Feb 2026 | 9:00 AM
25 Feb 2026 | 9:00 AM
Paragon Care Limited (PGC) Recent ASX Announcements
PGC Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | $27.31 | $1.70 | 83.30% | 27.10 | 0.00 | 0.00% | 0.0% |
| 2024A | $8.38 | $0.90 | -56.50% | 27.80 | 0.00 | 0.00% | 0.0% |
| 2023A | $16.61 | $2.10 | 4.00% | 14.70 | 1.20 | 3.90% | 100.0% |
PGC Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| EBOS Group Limited (EBO) | $3,688M | -0.1796 | -0.1005 | 0.1129 | 14.3814 | 15.9878 | 14.3663 | 6.08% | 4.37% | 4.87% |
| Paragon Care Limited (PGC) | $248M | 0.8333 | 0.0000 | 0.0000 | 9.0909 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Sigma Healthcare Limited (SIG) | $32,553M | 15.7941 | 0.0893 | 0.1688 | 49.3870 | 45.3376 | 38.7895 | 0.64% | 1.15% | 1.51% |
PGC Directors
| Name | Position | Start Date |
|---|---|---|
| Mr David Keith Collins | Chief Executive Officer, Managing Director | 3 Jun 2024 |
| Ms Carmen Rose Riley | Chief Operating Officer, Executive Director | 3 Jun 2024 |
| Mr Michael Sapountzis | Company Secretary | 22 Nov 2024 |
| Mr Peter Andre Lacaze | Non-Executive Chairman, Non-Executive Director | 3 Jun 2024 |
| Mr Peter John Egglestone | Non-Executive Director | 20 Mar 2025 |
Paragon Care Limited (PGC) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 30 Jun 2026 | WALSTAB, John | Sell | Direct Shares | 6,000,000 | $0.130 | $780,000.000 |
| 30 Jun 2026 | WALSTAB, John | Buy | Indirect Shares | 6,000,000 | $0.130 | $780,000.000 |
| 29 Jun 2026 | EGGLESTONE, Peter | Buy | Indirect Shares | 200,000 | $0.135 | $26,980.000 |
See all changes in directors' interest & trades for Paragon Care Limited (PGC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
PGC Management
| Name | Position |
|---|---|
| Marcus Crowe | Chief Financial Officer |
PGC Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Paragon Care Limited (PGC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 471,762,036 (28.50%) | Peter Andre Lacaze |
| 471,762,036 (28.50%) | David Keith Collins |
| 144,591,185 (8.73%) | John Walstab |
| 123,355,662 (7.45%) | Wilson Asset Management Group |
PGC Calendar of Events
| Date | Event |
|---|---|
| 24 February 2027 | Report (Interim) |
| 29 September 2026 | Report (Annual) |
| 29 September 2026 | Report (Prelim) |
| 26 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
